AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Metformin Hydrochloride; Glimepiride

10 registrations across 1 African market— 10 active

Markets with Metformin Hydrochloride; Glimepiride

Recent registrations

Brand / ProductMarketHolderStatusExpires
Co-Mepiryl Forte Tablet**
Tablet
🇳🇬NigeriaMay & Baker Nigeria PLCactiveJul 2029
Co-Mepiryl Tablet 2 mg/500 mg**
Tablet
🇳🇬NigeriaMay & Baker Nigeria PLCactiveJul 2029
Perglim M-2 Tablets
Tablet
🇳🇬NigeriaMega Lifesciences Nigeria LimitedactiveMar 2028
Glepid Plus Tablet
Tablet
🇳🇬NigeriaSeal Healthcare LimitedactiveMar 2028
Perglim M-2 Forte Tablets
Prolonged-release tablet
🇳🇬NigeriaMega Lifesciences Nigeria LimitedactiveMar 2028
Diapride Plus Tablets**
Tablet
🇳🇬NigeriaMicro Nova Pharmaceuticals Ind LtdactiveAug 2026
Suphage Tablet
Tablet
🇳🇬NigeriaSuperior Pharmaceuticals LimitedactiveMar 2026
Glavamet Tablets**
Tablet
🇳🇬NigeriaEvans Therapeutics LimitedactiveMar 2026
Zalvax M2 Tablets**
Tablet
🇳🇬NigeriaRoot Drugs Nigeria LimitedactiveJan 2026
Metformin Hydrochloride 500 mg & Glimepiride 2 mg Tablet
Tablet
🇳🇬NigeriaBrent Cross Pharmaceutical Co. LimitedactiveNov 2025

Metformin Hydrochloride; Glimepiride in Africa — Regulatory Overview

Metformin Hydrochloride; Glimepiride is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.